Furthermore, CHIP has garnered attention as a few recent large clinical trials have reported that CHIP is a risk factor for chronic kidney disease (CKD) (Vlasschaert et al., 2022; Kestenbaum et al., 2023) (Figure 1). This evidence concerns the gene STUB1 and chronic kidney disease.